UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

Molecular psychiatry, 2010-02, Vol.15 (2), p.138-145

2010

Link zum Volltext

Verfügbarkeit prüfen

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

Experimental neurology, 2010-06, Vol.223 (2), p.366-370

2010

Link zum Volltext

Verfügbarkeit prüfen

Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation

Journal of neurochemistry, 2002-05, Vol.81 (3), p.481-496

2002

Link zum Volltext

Verfügbarkeit prüfen

Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias

Molecular psychiatry, 2007-07, Vol.12 (7), p.671-680

2007

Link zum Volltext

Verfügbarkeit prüfen

Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations

Journal of Neural Transmission, 2007-05, Vol.114 (5), p.621-628

2007

Link zum Volltext

Verfügbarkeit prüfen

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies

Journal of Neural Transmission, 2006-11, Vol.113 (11), p.1771-1778

2006

Link zum Volltext

Verfügbarkeit prüfen

Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?

Journal of Neural Transmission, 2007-07, Vol.114 (7), p.919-927

2007

Link zum Volltext

Verfügbarkeit prüfen

Aminoterminally truncated and oxidized amyloid-beta peptide species in Alzheimer’s disease

Neuroscience, 2007-04, Vol.146 (1), p.17-18

2007

Link zum Volltext

Verfügbarkeit prüfen

Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease

Journal of Neural Transmission, 2005-06, Vol.112 (7), p.933-948

2005

Link zum Volltext

Verfügbarkeit prüfen

New perspectives in the laboratory diagnosis of dementia

Nervenarzt, 2008-11, Vol.79 Suppl 3, p.139-46; quiz 147-8

2008

Link zum Volltext

Verfügbarkeit prüfen

Neue Perspektiven in der laborchemischen Diagnostik bei Demenzen

Nervenarzt, 2008-12, Vol.79 (Suppl 3), p.139-148

2008

Link zum Volltext

Verfügbarkeit prüfen

Selective reduction of amyloid beta 42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation

Journal of neurology, neurosurgery and psychiatry, 2006-10, Vol.77 (10), p.1201-1203

2006

Link zum Volltext

Verfügbarkeit prüfen

Selective reduction of amyloid β42 discriminates Alzheimer’s disease from Huntington’s disease: indication for distinct pathological events in amyloid β peptide aggregation

Journal of neurology, neurosurgery and psychiatry, 2006-10, Vol.77 (10), p.1201-1203

2006

Link zum Volltext

Verfügbarkeit prüfen

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

Brain (London, England : 1878), 2006-05, Vol.129 (5), p.1177-1187

2006

Link zum Volltext

Verfügbarkeit prüfen

Stability of amyloid-β peptides in plasma and serum

Electrophoresis, 2012-02, Vol.33 (3), p.445-450

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides

Clinical chemistry (Baltimore, Md.), 2006-02, Vol.52 (2), p.332-334

2006

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloid β peptides

Electrophoresis, 2004-09, Vol.25 (17), p.2912-2918

2004

Link zum Volltext

Verfügbarkeit prüfen

Amyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease

Biological psychiatry (1969), 2004-03, Vol.55 (5), p.524-530

2004

Link zum Volltext

Verfügbarkeit prüfen

Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides

Proteomics. Clinical applications, 2012-04, Vol.6 (3-4), p.163-169

2012

Link zum Volltext

Verfügbarkeit prüfen

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases

Neuroscience letters, 2004-11, Vol.370 (1), p.36-39

2004

Link zum Volltext

Verfügbarkeit prüfen

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature

Journal of molecular neuroscience, 2004-01, Vol.23 (1-2), p.115-122

2004

Link zum Volltext

Verfügbarkeit prüfen

Quantification of amyloid-beta 40 in cerebrospinal fluid

Journal of immunological methods, 2009-08, Vol.348 (1), p.57-66

2009

Link zum Volltext

Verfügbarkeit prüfen

β-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

Annals of neurology, 2003-08, Vol.54 (2), p.263-267

2003

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review

Dementia and geriatric cognitive disorders, 2008-03, Vol.25 (3), p.256

2008

Link zum Volltext

Verfügbarkeit prüfen

Electrophoretic separation of amyloid β peptides in plasma

Electrophoresis, 2004-10, Vol.25 (20), p.3336-3343

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(35)
Humans
(30)
Aged
(23)
Male
(23)
Female
(22)
Neurosciences & Neurology
(22)
Middle Aged
(20)
Alzheimer's Disease
(17)
Amyloid Beta-Peptides - Cerebrospinal Fluid
(17)
Cerebrospinal Fluid
(17)
Neurology
(17)
Alzheimer Disease - Cerebrospinal Fluid
(15)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Neurosciences
(15)
Aged, 80 And Over
(14)
Clinical Neurology
(14)
Biomarkers - Cerebrospinal Fluid
(13)
Alzheimer Disease - Diagnosis
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

Highly conserved and disease‐specific patterns of carboxyterminally truncated Aβ peptides 1–37/38/39 in addition to 1–40/42 in Alzheimer's disease and in patients with chronic neuroinflammation

Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias

Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies

Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?

Aminoterminally truncated and oxidized amyloid-beta peptide species in Alzheimer’s disease

Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease

New perspectives in the laboratory diagnosis of dementia

Neue Perspektiven in der laborchemischen Diagnostik bei Demenzen

Selective reduction of amyloid beta 42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation

Selective reduction of amyloid β42 discriminates Alzheimer’s disease from Huntington’s disease: indication for distinct pathological events in amyloid β peptide aggregation

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

Stability of amyloid-β peptides in plasma and serum

Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides

Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloid β peptides

Amyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease

Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature

Quantification of amyloid-beta 40 in cerebrospinal fluid

β-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review

Electrophoretic separation of amyloid β peptides in plasma

Suchergebnisse filtern